The response and survival of children with recurrent diffuse intrinsic pontine glioma based on phase II study of antineoplastons A10 and AS2-1 in patients with brainstem glioma. [electronic resource]
Producer: 20150728Description: 2051-61 p. digitalISSN:- 1433-0350
- Adolescent
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Benzeneacetamides -- adverse effects
- Brain Stem Neoplasms -- drug therapy
- Child
- Child, Preschool
- Disease Progression
- Drug Combinations
- Female
- Glioma -- drug therapy
- Glutamine -- adverse effects
- Humans
- Infusions, Intravenous
- Male
- Neoplasm Recurrence, Local -- drug therapy
- Phenylacetates -- adverse effects
- Piperidones -- adverse effects
- Pons
- Survival Rate
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article
There are no comments on this title.
Log in to your account to post a comment.